GWAS in children
ESPID Education, Mike Levin, 179689
Epidemiology: GAS disease in Europe and in the world in 10 questions
ESPID Education, Pierre Smeesters, 179683
Transcriptomics: Clinical applications in Infectious Diseases
ESPID Education, Octavio Ramilo, 179688
Paediatric HIV: The European Contribution
ESPID Education, Carlo Giaquinto, 179682
RSV disease severity: Insights into protective host immune responses
ESPID Education, Santtu Heinonen, 179681
ESPID Young Investigator Award 2017 Ceremony: Cerebral Malaria - Clotting and broken barriers in the brain
ESPID Education, Christopher Moxon, 179679
ESPID Young Investigator Award 2017 Ceremony: B Cell responses and beyond - Johannes Trück
ESPID Education, Pierre Smeesters, 179676
ESPID Education and Communication Award Ceremony
ESPID Education, Shai Ashkenazi, 179670
A MULTIPLE ANTIGEN PRESENTING SYSTEM (MAPS) VACCINE AGAINST MYCOBACTERIUM TUBERCULOSIS PULMONARY INFECTION
ESPID Education, Rick Malley, 179669
THE IMPACT OF AGE AT VACCINATION ON INFANT VACCINE RESPONSES: AN ANALYSIS OF IMMUNITY IN 7630 CHILDREN
ESPID Education, Merryn Voysey, 179668
Systems vaccinology
ESPID Education, Rafick-Pierre Sekaly, 179667
Reverse vaccinology
ESPID Education, Rino Rappuoli, 179666
Why infections in different places need different vaccine programmes
ESPID Education, B. Gessner, 179665
PHARMACOKINETICS, SAFETY AND EFFICACY OF OMBITASVIR/PARITAPREVIR/RITONAVIR ± DASABUVIR ± RIBAVIRIN IN HEPATITIS C GENOTYPE 1 OR 4 VIRUS INFECTED ADOLESCENTS: THE ZIRCON STUDY
ESPID Education, Stefan Wirth, 179649
BUNDLE APPROACH TO REDUCE VENTILATOR ASSOCIATED PNEUMONIA IN NEONATES: A QUALITY IMPROVEMENT INITIATIVE IN AN OUTBORN NICU OF DELHI.
ESPID Education, Mamta Jajoo, 179659
MMR AND INFLUENZA VACCINATION COVERAGE AMONG MIGRANT CHILDREN IN FINLAND – A REGISTER-BASED STUDY
ESPID Education, Paula Tiittala, 179664
TRANSIENT TACHYPNEA OF THE NEWBORN IS ASSOCIATED WITH INCREASED RISK OF BRONCHIOLITIS IN INFANTS
ESPID Education, Otto Helve, 179653
LATENT TUBERCULOSIS INFECTION IN YOUNG REFUGEES AND ASYLUM SEEKING MIGRANTS; A MULTICENTRE CROSS-SECTIONAL STUDY
ESPID Education, Maya Mueller-Hermelink, 179663
IMMUNOGENICITY OF DIFFERENT DOSING SCHEDULES OF TRIVALENT INFLUENZA VACCINE IN HIV-INFECTED PREGNANT WOMEN: A RANDOMIZED CONTROLLED TRIAL
ESPID Education, Marta S.C. Nunes, 179652
FIRST OUTBREAK OF ENTEROVIRUS RELATED BRAINSTEM ENCEPHALITIS IN WESTERN EUROPE: CHARACTERIZATION, MANAGEMENT AND EVOLUTION OF THE PATIENTS
ESPID Education, Núria Worner Tomasa, 179647
IMMUNOLOGICAL RESPONSE TO TREATMENT IN HIV-INFECTED MIGRANT CHILDREN IN EUROPE AS COMPARED TO DOMESTIC-BORN COUNTERPARTS
ESPID Education, Malte Kohns, 179662
IMPACT OF A CARBAPENEM ANTIMICROBIAL STEWARDSHIP PROGRAMME ON PATIENT OUTCOMES IN A WOMEN’S AND CHILDREN’S HOSPITAL
ESPID Education, Xue Fen Valerie Seah, 179656
New respiratory viruses
ESPID Education, Adam Meijer, 179646
Vaccination programmes in refugee camps
ESPID Education, Markus Hufnagel, 179661
Treatment of MDR enterobacteria
ESPID Education, Jesús Rodríguez-Baño, 179655
Enterovirus/parechovirus
ESPID Education, Heli Harvala, 179645
Immunisation during pregnancy
ESPID Education, Flor Muñoz, 179650
Antimicrobial stewardship in children
ESPID Education, Theoklis Zaoutis, 179654
Antibiotic-resistant pathogens in refugee children
ESPID Education, Daniel Glikman, 179660
MARKERS OF RISK TO DEVELOP A SEVERE INFECTION IN CHILDREN WITH FEVER AND NEUTROPENIA RELATED TO CHEMOTHERAPY
ESPID Education, Jesus Saavedra-Lozano, 179638
ANTIBODY ADMINISTRATION EFFECTIVELY TREATS PERTUSSIS IN A BABOON DISEASE MODEL AND PROVIDES FIVE WEEKS OF PERTUSSIS PROPHYLAXIS IN NEWBORN BABOONS
ESPID Education, Jennifer Maynard, 179644
EARLY TREATMENT OF CHAGAS DISEASE PREVENTS CONGENITAL TRANSMISSION.
ESPID Education, Jaime Altcheh, 184348
VIRAL KINETICS AND TREATMENT OF CYTOMEGALOVIRUS INFECTIONS IN IMMUNOCOMPROMISED CHILDREN
ESPID Education, Ben Margetts, 179637
NEGATIVE CYTOMEGALOVIRUS PCR IN NEONATAL DRIED BLOOD SPOTS: CAN WE RULE CONGENITAL INFECTION OUT? A STUDY FROM THE SPANISH REGISTRY (REDICCMV)
ESPID Education, Isabel Vives-Oñós, 179627
MOLECULAR BACTERIOLOGICAL SURVEILLANCE OF PAEDIATRIC ENTERIC FEVER IN NEPAL BETWEEN 2008 AND 2015
ESPID Education, Carl Britto, 179631
PERTUSSIS ANTIBODIES IN ENTIRE POPULATION, AMONG PATIENTS WITH PERTUSSIS AND THE TIME COURSE UP TO THREE YEARS AFTER THE DISEASE
ESPID Education, Piia Jõgi, 179642
CLINICAL AND MICROBIOLOGICAL CHARACTERIZATION OF INVASIVE VIRIDANS GROUP STREPTOCOCCI INFECTIONS IN CHILDREN WITH CANCER, FEVER AND NEUTROPENIA, SANTIAGO, CHILE, 2004-2015
ESPID Education, María Carolina Rivacoba Rojas, 179635
Immunsing pregnant women – success and challenges
ESPID Education, Gayatri Amirthalingam, 179641
Congenital CMV
ESPID Education, Tiziana Lazzarotto, 179626
Viral infection in the child with HSCT
ESPID Education, Janet Englund, 179634
The search for a better pertussis vaccine
ESPID Education, Camille Locht, 179640
Typhoid disease burden
ESPID Education, John Crump, 179629
Risk factors in the neutropenic child
ESPID Education, Maria Elena Santolaya, 179633
Global Pertussis Initiative
ESPID Education, Stanley Plotkin, 179639
Future treatments for early treated HIV-infected children
ESPID Education, Jintanat Ananworanich, 179623
Immunological characteristics in early treated HIV-infected children
ESPID Education, Nigel Klein, 179622
Multi-level microbial biology in the light of evolution
ESPID Education, Fernando Baquero, 179619
DESCRIPTION OF PREVALENCE OF SYMPTOMS RELATED ZIKA VIRUS IN PREGNANT WOMEN WITH CHILDREN WITH MICROCEPHALY DURING THE FIRST YEAR OF EPIDEMIC IN PERNAMBUCO/BRAZIL
ESPID Education, Luiza Mello, 179617
Zika
ESPID Education, Karin Nielsen, 179616
Dengue
ESPID Education, Elisabeth Barnett, 179615
Chinkungunya
ESPID Education, Marco Safadi, 179614
INCREASING VACCINE COVERAGE - BARRIERS AND ATTITUDES
ESPID Education, Robb Butler, 134427
GETTING VACCINATED - ACCESS AND ATTITUDES
ESPID Education, Irina Ljungqvist, 134426
COMPARISON OF CHILDREN TESTING NEGATIVE AND POSITIVE FOR EBOLA VIRUS DISEASE IN EBOLA HOLDING UNITS, SIERRA LEONE
ESPID Education, Felicity Fitzgerald, 132227
RTSS MALARIA VACCINE., DOES IT WORK? IS IT SAFE?
ESPID Education, Brian Greenwood, 132228
TO LP OR NOT TO LP: SAFETY OF LUMBAR PUNCTURE IN COMATOSE CHILDREN WITH CLINCIAL FEATURES OF CEREBRAL MALARIA
ESPID Education, Christopher Moxon, 132229
REFUGEES ARRIVING IN EUROPE: THE MUNICH PAEDIATRIC INFECTION EXPERIENCE
ESPID Education, Ulrich von Both, 132230
VACCINE HESITANCY - THE EMERGENCE OF GLOBAL MISUNDERSTANDING
ESPID Education, Emilie Karafillakis, 134428
RSV - NEW THERAPEUTIC HORIZONS BRING CLINICAL CHALLENGES
ESPID Education, Steve Cunningham, 132215
SEASONAL AND PANDEMIC INFLUENZA IN PAEDIATRIC INTENSIVE CARE UNITS IN ENGLAND AND WALES: RISK FACTORS FOR ADMISSION AND MORTALITY
ESPID Education, Pia Hardelid, 132216
DIAGNOSIS AND PATHOPHYSIOLOGY OF BIOFILM INFECTIONS IN CYSTIC FIBROSIS
ESPID Education, Niels Hoeiby, 132217
DEXAMETHASONE FOR PLEURAL INFECTION IN CHILDREN: A DOUBLE BLIND, RANDOMIZED, CLINICAL TRIAL OF EFFICACY AND SAFETY
ESPID Education, ALFREDO TAGARRO, 132218
NASOPHARYNGEAL BACTERIAL DENSITY IS INCREASED BY VIRAL RESPIRATORY INFECTIONS WHICH MAY FACILITATE TRANSMISSION
ESPID Education, Valtyr Thors, 132219
HIGHLIGHTS & LESSONS FROM THE FIRST 17 YEARS OF THE BRIGHTON COLLABORATION
ESPID Education, Jan Bonhoeffer, 132220
ENHANCING VACCINE SAFETY CAPACITY GLOBALLY: A LIFECYCLE PERSPECTIVE
ESPID Education, Robert Chen, 132221
NO ASSOCIATION OF THE TEN-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV10) WITH PREVIOUSLY SUGGESTED PCV SAFETY SIGNALS
ESPID Education, Arto A Palmu, 132222
INFLUENZA VACCINATION IN CHILDREN WITH CYSTIC FIBROSIS USING INTRANASAL LIVE ATTENUATED INFLUENZA VACCINE: EXPERIENCE FROM AN AUSTRIAN PAEDIATRIC HOSPITAL
ESPID Education, Sabine Renner, 132223
EXPLORING INCIDENCE RATES OF GUILLIAIN BARR
ESPID Education, Jozica Skufca, 132224
MEASUREMENT OF FEVER AFTER INFANT IMMUNISATIONS: COMPARISON OF INTERMITTENT AND 24 HOURS CONTINUOUS MONITORING
ESPID Education, Marta Valente Pinto, 132225
USING SMS TECHNOLOGY FOR REAL-TIME SURVEILLANCE OF ADVERSE EVENTS FOLLOWING IMMUNISATION
ESPID Education, Darren Westphal, 132226
THE RESURGENCE OF PERTUSSIS: FACTS, FICTION, MYTHS AND MISCONCEPTIONS?
ESPID Education, James Cherry, 132214
BILL MARSHALL LECTURE & AWARD: INTRODUCTION
ESPID Education, Adam Finn, 135835
ESCAPETB PROJECT -ENVIRONMENTAL SURVEILLANCE IN CANADA AND CAPE TOWN - IMPROVING OUR UNDERSTANDING OF AIRBORNE PATHOGEN EXPOSURE WITH A FOCUS ON TRANSMISSION OF ROD-SHAPED (MYCO-)BACTERIA)
ESPID Education, Koen Vanden Driessche, 132208
DISCOVERY OF IMMUNODOMINANT B CELL EPITOPES WITHIN SURFACE PNEUMOCOCCAL VIRULENCE PROTEINS IN PEDIATRIC PATIENTS WITH INVASIVE PNEUMOCOCCAL DISEASE
ESPID Education, Theano Lagousi, 132206
IMMUNOGENICITY OF REDUCED DOSE PRIMING SCHEDULES OF SEROGROUP C MENINGOCOCCAL CONJUGATE VACCINE FOLLOWED BY BOOSTER AT 12 MONTHS IN INFANTS: OPEN LABEL RANDOMISED CONTROLLED TRIAL
ESPID Education, David Pace, 132205
HOW DOES THE GUT-MICROBIOTA INFLUENCE THE ONSET AND NATURE OF JUVENILE IDIOPATHIC ARTHRITIS?
ESPID Education, Paula Sanchez-Moreno, 132203
ZIKA VÍRUS AND GESTATION: FIRST CASES DETECTED IN SERGIPE
ESPID Education, Eitan Berezin, 132197
EARLY ANTIRETROVIRAL THERAPY PRESERVES THYMIC OUTPUT IN CHILDREN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS: EVIDENCE FROM THE CHILDREN WITH HIV EARLY ANTIRETROVIRAL THERAPY (CHER) TRIAL
ESPID Education, Helen Payne, 132198
PROTECTING AGAINST THE CHANGELING DEMON AND THE TROLL OF TRANSPLANTATION
ESPID Education, Stanley Plotkin, 132199
USING BIOMARKERS TO GUIDE MANAGEMENT IN THE EMERGENCY DEPARTMENT
ESPID Education, Alain Gervaix, 132182
CLINICAL SIGNS AND POINT OF CARE TESTING IN FEBRILE CHILDREN
ESPID Education, Henriette Moll, 132183
PREVENTING EBOLA - THE RING VACCINATION STUDY
ESPID Education, Ana Maria Henao-Restrepo, 132187
NEUROLOGICAL AND AUTOIMMUNE COMPLICATIONS OF ZIKA VIRUS INFECTION
ESPID Education, Marco Safadi, 132188
A PRACTICAL GUIDE TO GETTING THE DOSE RIGHT
ESPID Education, Roger Brüggemann, 132189
PHARMACOKINETIC (PK) MODELLING OF MEROPENEM IN PLASMA AND CEREBROSPINAL FLUID (CSF) IN INFANTS WITH LATE-ONSET SEPSIS (LOS) AND/OR BACTERIAL MENINGITIS
ESPID Education, Eva Germovsek, 132190
PHARMACOMETRIC MODELS AND IN SILICO STUDIES
ESPID Education, Marc Pfister, 132192
POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF TEICOPLANIN IN NEONATES
ESPID Education, Virginia Ramos Martin, 132193
IS IMMUNISING CHILDREN REALLY THE BEST WAY TO PROTECT THE ELDERLY AGAINST FLU?
ESPID Education, Marc Baguelin, 132194
UNIVERSAL CHILDHOOD VARICELLA VACCINE - MODELLING AND ETHICAL CONSTRUCTS
ESPID Education, Philippe Beutels, 132195
EPIDEMIOLOGY AND VACCINE EFFECTIVENESS DURING A LARGE MUMPS OUTBREAK IN WESTERN AUSTRALIA
ESPID Education, Darren Westphal, 134425
CONTROL OF HIB IN CHILDREN: EPIDEMIOLOGY AND SEROPREVALENCE IN ENGLAND
ESPID Education, Sarah Collins, 134424
PROSPECTIVE VALIDATION OF LIPOCALIN-2 AS A PREDICTOR OF BACTERIAL INFECTION IN CHILDREN: A HOSPITAL-BASED STUDY.
ESPID Education, Climent Casals-Pascual, 132170
ADVANCES IN PATHOGEN DETECTION
ESPID Education, Mark Nicol, 132172
Diagnostics in a Digital Age: A Paediatric Perspective
ESPID Education, Rosanna Peeling, 132173
UNRAVELLING THE GENETICS OF MENINGOCOCCAL DISEASE: THE FACTOR H STORY REVISITED
ESPID Education, Sonia Maria Davila Dominguez, 132174
AN OVERVIEW OF GENETIC SUSCEPTIBILITY TO VIRAL INFECTIONS
ESPID Education, Vanessa Sancho Shimizu, 132175
AN OVERVIEW OF GENETIC SUSCEPTIBILITY TO FUNGAL INFECTIONS
ESPID Education, Frank van de Veerdonk, 132176
PRAGMATIC COMMUNITY ANTIMICROBIAL TRIALS IN CHILDREN AND ADULTS
ESPID Education, Paul Little, 132177
MEROPENEM VS STANDARD OF CARE ANTIBIOTICS (SOC) FOR LATE ONSET NEONATAL SEPSIS (LOS): A RANDOMIZED CONTROLLED TRIAL NEOMERO-1
ESPID Education, Irja Lutsar, 132178
FEBRILE URINARY TRACT INFECTION DUE TO EXTENDED-SPECTRUM BETA-LACTAMASE-PRODUCING ENTEROBACTERIACEAE IN CHILDREN: AN OBSERVATIONAL FRENCH STUDY
ESPID Education, Fouad MADHI, 132179

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings